GIVOSIRAN vs GLIMEPIRIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GIVOSIRAN vs GLIMEPIRIDE: Safety Overview
| Metric | GIVOSIRAN | GLIMEPIRIDE |
|---|---|---|
| Total FAERS Reports | 1,224 | 5,572 |
| Deaths Reported | 32 | 552 |
| Death Rate | 2.6% | 9.9% |
| Hospitalizations | 595 | 2,550 |
| Average Patient Age | 45.1 yrs | 66.6 yrs |
| % Female Patients | 89.5% | 46.4% |
| FDA Approval Date | Nov 20, 2019 | Apr 17, 2013 |
| Manufacturer | Alnylam Pharmaceuticals, Inc. | A-S Medication Solutions |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | Prescription | Discontinued |